Latest Breaking News On - தயாரிப்பாளர்கள் ஆய்வகம் - Page 1 : comparemela.com
Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Tech Mahindra expects to begin trials for planned Covid drug in 3-4 months
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.
UoH startup suggests use of anti-diabetic drug Ertugliflozin against Covid
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.
Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirus
SECTIONS
Last Updated: May 02, 2021, 06:48 PM IST
Share
Synopsis
Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra.
Getty Images
IT company
Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official. Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done.
IT company Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official.
Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told PTI that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra. We have found a molecule that can potentially attack coronavirus. We have applied for a joint patent and cannot reveal the name of the molecule unless the patent process is completed, Malhotra said.